Cargando…
The 5Rs dilemma of radiotherapy for non-malignant diseases: 5Rs to darken OR 5Rs to shine
Many benign diseases, so called because they are not a direct cause of death, nevertheless cause significant damage to the health of patients due to the associated pain, reduced functionality, increased disability and the negative impact they have on quality of life, which, together with the limited...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Via Medica
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132200/ https://www.ncbi.nlm.nih.gov/pubmed/37122917 http://dx.doi.org/10.5603/RPOR.a2023.0001 |
_version_ | 1785031344703668224 |
---|---|
author | Montero, Angel Alvarez, Beatriz |
author_facet | Montero, Angel Alvarez, Beatriz |
author_sort | Montero, Angel |
collection | PubMed |
description | Many benign diseases, so called because they are not a direct cause of death, nevertheless cause significant damage to the health of patients due to the associated pain, reduced functionality, increased disability and the negative impact they have on quality of life, which, together with the limited efficacy of many of the available treatments, make their management a challenge for every specialist. Radiotherapy, which has demonstrated its efficacy not only against cancer but also in many non-tumorous diseases, appears as a therapeutic option that deserves to be taken into account. However, there is still much resistance to considering the use of radiotherapy as a valid and acceptable alternative. The 5Rs to darken summarize the doubts and contradictions many specialists face to accept radiotherapy in non-neoplastic diseases. However, other 5Rs (to shine) can be argued to claim for the safety, reliability, and usefulness of radiation treatment for benign disease and as radiotherapy specialists we have to help the evidence shine and the darkness disappear. |
format | Online Article Text |
id | pubmed-10132200 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Via Medica |
record_format | MEDLINE/PubMed |
spelling | pubmed-101322002023-04-27 The 5Rs dilemma of radiotherapy for non-malignant diseases: 5Rs to darken OR 5Rs to shine Montero, Angel Alvarez, Beatriz Rep Pract Oncol Radiother Review Article Many benign diseases, so called because they are not a direct cause of death, nevertheless cause significant damage to the health of patients due to the associated pain, reduced functionality, increased disability and the negative impact they have on quality of life, which, together with the limited efficacy of many of the available treatments, make their management a challenge for every specialist. Radiotherapy, which has demonstrated its efficacy not only against cancer but also in many non-tumorous diseases, appears as a therapeutic option that deserves to be taken into account. However, there is still much resistance to considering the use of radiotherapy as a valid and acceptable alternative. The 5Rs to darken summarize the doubts and contradictions many specialists face to accept radiotherapy in non-neoplastic diseases. However, other 5Rs (to shine) can be argued to claim for the safety, reliability, and usefulness of radiation treatment for benign disease and as radiotherapy specialists we have to help the evidence shine and the darkness disappear. Via Medica 2023-04-06 /pmc/articles/PMC10132200/ /pubmed/37122917 http://dx.doi.org/10.5603/RPOR.a2023.0001 Text en © 2023 Greater Poland Cancer Centre https://creativecommons.org/licenses/by-nc-nd/4.0/This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially |
spellingShingle | Review Article Montero, Angel Alvarez, Beatriz The 5Rs dilemma of radiotherapy for non-malignant diseases: 5Rs to darken OR 5Rs to shine |
title | The 5Rs dilemma of radiotherapy for non-malignant diseases: 5Rs to darken OR 5Rs to shine |
title_full | The 5Rs dilemma of radiotherapy for non-malignant diseases: 5Rs to darken OR 5Rs to shine |
title_fullStr | The 5Rs dilemma of radiotherapy for non-malignant diseases: 5Rs to darken OR 5Rs to shine |
title_full_unstemmed | The 5Rs dilemma of radiotherapy for non-malignant diseases: 5Rs to darken OR 5Rs to shine |
title_short | The 5Rs dilemma of radiotherapy for non-malignant diseases: 5Rs to darken OR 5Rs to shine |
title_sort | 5rs dilemma of radiotherapy for non-malignant diseases: 5rs to darken or 5rs to shine |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132200/ https://www.ncbi.nlm.nih.gov/pubmed/37122917 http://dx.doi.org/10.5603/RPOR.a2023.0001 |
work_keys_str_mv | AT monteroangel the5rsdilemmaofradiotherapyfornonmalignantdiseases5rstodarkenor5rstoshine AT alvarezbeatriz the5rsdilemmaofradiotherapyfornonmalignantdiseases5rstodarkenor5rstoshine AT monteroangel 5rsdilemmaofradiotherapyfornonmalignantdiseases5rstodarkenor5rstoshine AT alvarezbeatriz 5rsdilemmaofradiotherapyfornonmalignantdiseases5rstodarkenor5rstoshine |